Los Alamos Replies

The article "Cruel Wind From The North For Los Alamos" that appeared in the October 17 issue of The Scientist (page 2) probably provided a service to your readers in bringing a sensitive and interesting issue to their attention. The Canadian government has approached the Department of Energy (DOE) and the National Science Foundation (NSF) seeking $75 million to assist in the construction of a "kaon factory" in Vancouver, British Columbia. The Canadians are also seeking financial support from o

Written byGerald Garvey
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The article "Cruel Wind From The North For Los Alamos" that appeared in the October 17 issue of The Scientist (page 2) probably provided a service to your readers in bringing a sensitive and interesting issue to their attention. The Canadian government has approached the Department of Energy (DOE) and the National Science Foundation (NSF) seeking $75 million to assist in the construction of a "kaon factory" in Vancouver, British Columbia. The Canadians are also seeking financial support from other countries interested in this area of research. Their proposal would use the present TRIUMF cyclotron as the injector stage of the proposed facility. The DOE and NSF have asked their Nuclear Science Advisory Committee (NSAC) to provide input in formulating a response to the Canadian request. NSAC thereupon established a subcommittee that must assess, among other considerations, the impact of supporting the Canadian endeavor on present activities at the Los ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies